- Home
- SPRY vs NMM Comparison
SPRY vs NMM Comparison
Compare SPRY & NMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- NMM
- Stock Information
- Founded
- SPRY 2015
- NMM 2007
- Country
- SPRY United States
- NMM Monaco
- Employees
- SPRY N/A
- NMM N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- NMM Marine Transportation
- Sector
- SPRY Health Care
- NMM Consumer Discretionary
- Exchange
- SPRY Nasdaq
- NMM Nasdaq
- Market Cap
- SPRY 1.1B
- NMM 1.3B
- IPO Year
- SPRY N/A
- NMM 2007
- Fundamental
- Price
- SPRY $11.24
- NMM $43.65
- Analyst Decision
- SPRY Strong Buy
- NMM Strong Buy
- Analyst Count
- SPRY 4
- NMM 1
- Target Price
- SPRY $26.00
- NMM $80.00
- AVG Volume (30 Days)
- SPRY 1.2M
- NMM 105.3K
- Earning Date
- SPRY 03-20-2025
- NMM 02-13-2025
- Dividend Yield
- SPRY N/A
- NMM 0.46%
- EPS Growth
- SPRY N/A
- NMM N/A
- EPS
- SPRY N/A
- NMM 12.15
- Revenue
- SPRY $2,568,000.00
- NMM $1,334,066,000.00
- Revenue This Year
- SPRY $68,783.34
- NMM N/A
- Revenue Next Year
- SPRY $503.87
- NMM $6.96
- P/E Ratio
- SPRY N/A
- NMM $3.59
- Revenue Growth
- SPRY 8460.00
- NMM 2.08
- 52 Week Low
- SPRY $7.55
- NMM $32.75
- 52 Week High
- SPRY $18.51
- NMM $65.89
- Technical
- Relative Strength Index (RSI)
- SPRY 37.72
- NMM 48.47
- Support Level
- SPRY $11.58
- NMM $42.22
- Resistance Level
- SPRY $12.43
- NMM $45.65
- Average True Range (ATR)
- SPRY 0.72
- NMM 1.50
- MACD
- SPRY -0.14
- NMM 0.24
- Stochastic Oscillator
- SPRY 0.53
- NMM 58.16
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About NMM Navios Maritime Partners LP Common Units Representing Limited Partner Interests
Navios Maritime Partners LP is a seaborne shipping company. It owns and operates dry cargo and container vessels with the primary long-term and staggered expiration charters. The firm's fleet consists of Ultra- Handymax, Panamax, Capsize, and Container vessels and categorized in Drybulk and Container vessels. It earns revenue through chartering of vessels, voyage contracts. Geographically, it generates majority revenue from Asia.